A review of potential neuropathological changes associated with ketamine
Expert Opinion on Drug Safety May 3, 2022 Danica Nogo, Hana Nazal, Yuetong Song et al. 17 citations
INTRODUCTION: Ketamine is an established intervention for treatment-resistant depression (TRD). However, long-term adverse effects with repeated doses remain insufficiently characterized. Although several animal models have shown N-methyl-D-aspartate glutamate receptor antagonists to produce various neuropathological reactions, attention surrounding the risk of brain lesions has been minimal....
DOI: 10.1080/14740338.2022.2071867 (opens in new tab)
Ketamine
Treatment-resistant depression
Neuropathology
Anesthetic
+8